Johnson & Johnson has kept global access at the heart of its COVID-19 vaccine supply efforts, pledging 500 million doses to lower-income countries late last year. Now, the drugmaker is setting aside another quarter-billion doses to shore up vaccination efforts in Africa.
Johnson & Johnson locked up a deal to provide the African Union with up to 400 million doses of its one-and-done COVID-19 vaccine through 2022, to be rolled out as it’s approved by the bloc’s 55 member states.
J&J will sell the African Vaccine Acquisition Trust (AVAT) up to 220 million doses to start, with the option to sell another 180 million shots in the future. Deliveries from the initial tranche should kick off in the third quarter of 2021, while the remaining doses will be supplied through next year, J&J said in a release.
Read more: https://www.fiercepharma.com/pharma/johnson-johnson-pledges-400m-single-dose-covid-19-vaccines-to-african-union